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Abstract 
Background: Recent pooled analyses support a 
beneficial impact of nut consumption on health, but 
whether nuts are associated with overall decreased 
mortality has not been yet reviewed. 
Objective: We aimed to systematically review 
prospective studies exploring the effects of nut 
consumption on all-cause, cardiovascular disease (CVD), 
and cancer mortality and quantify the size effect through 
meta-analysis. We also reviewed confounding factors 
associated with nut consumption to assess potential 
clustering with other covariates. 
Design: We searched PubMed and EMBASE for studies 
published up to June 2014. Study characteristics, hazard 
ratios (HRs) and 95% confidence intervals (CIs) were 
generated based on quantitative analyses. Dose-response 
analysis was performed when data were available. 
Results: Seven studies for all-cause, six for CVD, and 
two for cancer mortality were included in this meta-
analysis, with a total of 354,933 participants, 44,636 
cumulative incident deaths and 3,746,534 cumulative 
person-years. Nut consumption was associated with some 
baseline characteristics, such as lower BMI and smoking 
status, as well as with increase intake of fruit, vegetable, 
and alcohol. One-serving of nuts per week and per day 
resulted in 4% (RR 0.96, 95% CI 0.93, 0.98) and 27% 
(RR 0.73, 95% CI 0.60, 0.88) decreased risk of all-cause 
mortality, respectively, and decreased risk of CVD 
mortality (RR: 0.93; 95% CI: 0.88, 0.99 and RR: 0.61; 
95% CI: 0.42, 0.91, respectively). The effects were 
primarily driven by decreased coronary heart disease 
rather than stroke deaths. Nut consumption was also 
associated with a decreased risk of cancer death when 
comparing highest vs. lowest category of intake (RR: 
0.86; 95% CI, 0.75, 0.98), but no dose-effect was found. 
Conclusions: Nut consumption is associated with lower 
risk of all-cause, CVD, and cancer mortality, but 
presence of confounding factors should be taken into 
account when considering such findings. 
Keywords: Nut consumption; mortality; prospective 
studies; cardiovascular diseases; cancer. 
Introduction 
Plant-based dietary patterns have been shown to have 
positive and significant impacts on human health over the 
last century (1). While most epidemiological studies have 
focused on fruits, vegetables, legumes, or cereals and 
morbidity/ mortality from chronic disease, a limited 
number of cohort studies have examined nut consumption 
and its potential beneficial effects on health outcomes (2). 
Nuts are a specific kind of fruit characterized by a hard 
shell and a dry seed rich in vitamins, phenolic 
compounds, fiber, and minerals, as well as  high 
unsaturated fatty acid content relatively unique for fruits 
(3). Beneficial effects of nut consumption have been 
reported in relation to both cardiovascular disease (CVD) 
and cancer, although results on the latter are equivocal 
(2). Possible mechanisms of CVD risk reduction include 
anti-inflammatory, antioxidant, and anti-atherogenic 
properties of compounds such as tocopherols, folic acids, 
and phytochemicals that are common in nuts (3). Nut 
consumption has been demonstrated to have beneficial 
effects on several cardiovascular risk factors, including 
lowering low-density lipoprotein cholesterol (LDL-c) (4), 
ameliorating endothelial function (5), decreasing visceral 
adiposity (6), improving hyperglycemia (7) and insulin 
resistance (8). Furthermore, nutrients contained in nuts 
may also modify specific processes related to cancer 
development, such as regulation of cell differentiation 
and proliferation, reduction of tumor initiation or 
promotion, DNA protection, and regulation of 
immunological and inflammatory responses (9). 
 
Four recent meta-analyses demonstrated that higher 
consumption of nuts was associated with reduced risk of 
coronary artery disease and hypertension (10-13). 
However, pooled analyses exploring the effects of nut 
consumption on all-cause, CVD, and cancer mortality are 
lacking. Therefore, we aimed to systematically review 
prospective cohort studies investigating the association 
between nut consumption and mortality and review 
confounding factors associated with nut consumption to 
assess potential clustering with other covariates. 
Methods 
Study selection 
A comprehensive search on MEDLINE and EMBASE 
databases of all English language studies on nut 
consumption and mortality published up to June 2014 
was performed. Articles of potential interest were 
identified by using the search term “nut” combined with 
the terms: “mortality” or “survival”. Among the 240 
articles retrieved, prospective cohort studies were 
identified and screened by reading the abstract and the 
full text when necessary. The reference lists of included 
manuscripts were also examined for any additional study 
not previously identified. The process of identification 
and inclusion of studies is summarized in Figure 1. 
Studies meeting the inclusion criteria: (i) evaluated the 
effects of nut consumption on the risk of mortality; (ii) 
assessed nut consumption by relative levels of intake 
(i.e., frequency or quantiles of consumption); and (iii) 
used a prospective cohort design. Exclusion criteria were: 
(i) studies reporting insufficient statistics or results; (ii) 
assessed nut consumption in combination with other food 
groups. If more than one article was published that used 
the same cohort, only the study including the entire 
cohort or with the longest follow-up was included. 
Data extraction 
Data were abstracted from each identified study by using 
a standardized extraction form. The following 
information was extracted from each study: i) name of 
the first author; ii) year of publication; iii) study cohort; 
iv) country; v) number of participants; vi) gender of 
participants; vii) age range of the study population at 
baseline; viii) follow-up period; ix) endpoints and cases; 
x) distributions of cases and person years, hazard ratios 
(HRs) and 95% confidence intervals (CIs) for all 
categories of exposure; xi) covariates used in 
adjustments; xii) background characteristics by categories 
of exposure. This process was independently performed 
by GG and SM; and any discordant entries were 
discussed and resolved by consensus.   
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The quality of each study was assessed according to 
Newcastle-Ottawa quality assessment Scale (14), 
consisting of three parameters of quality: selection (four 
points), comparability (two points), and outcome (three 
points); with a score of seven or more reflecting high 
quality. We also included the following additional 
criteria: completeness and accuracy of results (presence 
of person-years), ascertainment of exposure (nut 
consumption) with the outcomes of interest, number of 
participants (> 5000), duration of follow-up (>5 years), 
and adjustment for potential confounders (adequate vs. 
lacking of key confounders), for a total score of 14 
points.  
Statistical analysis 
The outcomes evaluated in the analyses included all-
cause, CVD, and cancer mortality. In the model 
evaluating CVD mortality, when a study evaluated 
specific CVD cause of death (i.e., coronary heart disease 
[CHD] or stroke), we included the most specific 
outcomes in order to control for possible differences 
across diseases. 
HRs with 95% CIs for all categories of exposure were 
extracted for the analysis and random-effects models 
were used to calculate pooled relative risks (RRs) with 
95% CIs for highest compared with lowest category of 
exposure and the dose-response analysis. Heterogeneity 
was assessed by using the Q test and I2 statistic. The level 
of significance for the Q test was defined as P <0.10. The 
I2 statistic represents the amount of total variation that 
could be attributed to heterogeneity. I2 values ≤25%, 
≤50%, ≤75% and >75% indicated no, little, moderate, 
and significant heterogeneity, respectively. A sensitivity 
analysis excluding one study at a time was performed to 
assess the stability of results and potential sources of 
heterogeneity. A meta-regression analysis was conducted 
to test the effects on risk estimates as sources of 
heterogeneity of potential confounding factors 
considering year of publication, study quality, duration of 
follow-up, and amount of nut consumption in the highest 
category of exposure as moderators. We examined these 
hypothesized variables by fitting a mixed-effect model 
including such variables as moderators. To facilitate the 
interpretation of the effect of moderators, we obtained 
predicted average RRs by fitting four meta-regression 
models including each variable. Pooled effects were 
estimated via weighted least squares linear regression 
with natural logarithm of each study specific HR as 
dependent variable and with weights equal to the inverse 
of the sum of the within-study variance and the residual 
between-study variance. Publication bias was evaluated 
by visual investigation of funnel plots for potential 
asymmetry. 
For dose-response analyses, the method reported by 
Greenland et al (15) and Orsini et al (16) was used to 
calculate study specific slopes (“corrected” linear trends) 
on the basis of results across categories of nut 
consumption. We extracted data on the amount of nut 
consumption, distributions of cases and person-years, and 
HRs with 95% CIs for ≥3 exposure categories. The 
median or mean weekly and daily amount of nut 
consumption in each category was assigned to the 
corresponding HR with the 95% CI for each study. When 
nut consumption was reported by ranges of intakes, the 
midpoint of the range was used. When the highest 
category was open ended, we assumed the width of the 
category to be the same as the adjacent category. When 
the lowest category was open ended, we set the lower 
boundary to zero. Due to lack of person-years data in 
some studies, we additionally evaluated dose-response 
effect by calculating the “uncorrected” linear trend 
performing weighted least squares regression using HRs 
and CIs extracted for each intake category. 
Background characteristics by category of exposure were 
graphically plotted to evaluate possible correlations. For 
each study, linear regression coefficients between nut 
consumption and alcohol, fruit, vegetable, and red meat 
intakes, as well as BMI and prevalence of smoking were 
estimated and subsequently meta-analyses to pool slope 
coefficients performed.  
All analyses were performed in Review Manager 
(RevMan) version 5.2 (Copenhagen: The Nordic 
Cochrane Centre, The Cochrane Collaboration) and R 
version 3.0.3 (Development Core Team, Vienna, 
Austria). 
Results 
Characteristics of included prospective studies 
Eighteen out of the 25 originally selected studies were 
excluded after full-text examination for the following 
reasons: 1 study reported insufficient statistics; 1 study 
was conducted on subgroups of a cohort entirely 
evaluated in another study; 4 studies were conducted on 
same cohorts but with shorter follow-up periods; 12 
studies explored the consumption of nuts grouped with 
other foods. Two additional studies meeting the inclusion 
criteria were identified by hand searching reference lists. 
This inclusion strategy resulted in the final selection of 9 
studies (17-25) (Figure 1) with a total of 354,933 
participants, 44,636 cumulative incident deaths and 
3,746,534 cumulative person-years eligible to be included 
in the systematic review (Table 1). Geographically, these 
studies included 8 cohorts from the United States (US) 
(17-20, 23, 24), the Netherlands (21) and Spain (22, 25). 
Most of the studies examined individuals between the 
ages of 40 and 70. All studies included covariates that 
may have significant influence on mortality outcomes, 
such as age, gender (when not analyzed separately), body 
mass index (BMI), education, physical activity and 
smoking status. The covariates used for adjustments are 
described in Table 1. In general, study quality was good 
and comparable among different cohorts, despite one 
report (24) presented substantial limitations due to that it 
was published in the format of a conference abstract (see 
Supplemental Table 1 under “Supplemental data” 
online). In addition, only 2 studies (19, 21) were 
conducted on general population. 
Nut consumption and all-cause mortality 
Six studies (18, 19, 22-25) were pooled together to 
estimate the risk of death in individuals with the highest 
intake of nuts compared to the lowest. The analysis 
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revealed an overall inverse association between higher 
nut consumption and all-cause mortality (RR 0.77, 95% 
CI 0.69, 0.87; Figure 2) with moderate evidence of 
heterogeneity (I2 = 56%). A sensitivity analysis was 
performed by exclusion of one study at a time and 
heterogeneity dropped to 49% when excluding Guasch-
Ferré et al (22) which accounted for the highest weight 
(9.8%) amongst included studies. However, no 
substantial changes in the pooled risk estimate were 
found (RR: 0.80, 95% CI: 0.73, 0.89). The funnel plot 
suggested a publication bias against non-significant 
findings of benefit or harm associated with nuts or, 
analogously, toward findings with large effect sizes in 
favor of nuts  (see Supplemental Figure 1A under 
“Supplemental data” online). After exclusion of these 
studies from the analysis, pooled RR still indicated a 20% 
decrease in all-cause mortality risk for highest category 
of nut consumption (RR: 0.80, 95% CI: 0.73, 0.89). 
Results of the meta-regression analysis showed none of 
the moderators examined had affected the analysis and 
therefore could potentially explain for the heterogeneity 
we observed (see Supplemental Table 2 and 
Supplemental Figure 2 under “Supplemental data” 
online).	 
Dose-response analysis exploring the effects of 
consuming 1-serving of nuts per week and per day was 
examined in 5 studies (19, 21-23, 25). We excluded 
studies that did not report detailed information on person-
years (18, 24) and included Van den Brandt et al (21), 
which  reported HRs for nut consumption frequency by 
treating it as a continuous variable. One-serving per week 
and per day resulted in 4% (RR: 0.96, 95% CI: 0.93, 
0.98) and 27% (RR: 0.73, 95% CI: 0.60, 0.88) decreased 
risk of all-cause mortality, respectively (Figure 2). We 
observed moderate heterogeneity (I2 = 53%) and 
evidence of publication bias at funnel plot especially for 
1-serving per week (see Supplemental Figure 1B and 
Supplemental Figure 1C under “Supplemental data” 
online). Heterogeneity and publication bias were due to 
the same aforementioned studies and their exclusion led 
to comparable but more consistent results (I2 = 0%) with 
no significant change in the final results (RR: 0.97, 95% 
CI: 0.96, 0.98 for 1-serving/week and RR: 0.81, 95% CI: 
0.77, 0.86 for 1-serving/day). However, although the 
absolute difference in the RR estimates seem negligible, 
excluding two of the five studies causes a significant 
attenuation in the RR results of approximately 25% for 
weekly and 30% for daily consumption. Additional dose-
response analysis that included all studies strengthened 
the effect size for both weekly (RR: 0.93, 95% CI: 0.90, 
0.96) and daily (RR: 0.59, 95% CI: 0.48, 0.74) 
consumption of nuts on risk of all-cause mortality (see 
Supplemental Figure 3 under “Supplemental data” 
online).  
Nut consumption and CVD mortality 
The association between nut consumption and CVD 
mortality was evaluated pooling data from 6 studies (17, 
19, 20, 22-24) accounting for 7775 deaths from CVD. 
High consumption of nuts was inversely associated with 
CVD mortality risk compared to those with the lowest 
category of intake (RR: 0.71; 95% CI: 0.62, 0.81; Figure 
3). We observed no significant evidence of heterogeneity 
(I2 = 25%) or publication bias (see Supplemental Figure 
4A under “Supplemental data” online). After sensitivity 
analysis, no significant change of results was found. 
However, meta-regression analysis revealed a significant 
association with duration of follow-up as potential source 
of heterogeneity (see Supplemental Table 2 and 
Supplemental Figure 5 under “Supplemental data” 
online), as longer follow-up duration was associated with 
increased risk toward null effect. 
Pooled RR to estimate HRs for 1-serving of nuts per 
week and per day was applied to 4 studies (19, 20, 22, 
23) and resulted in decreased risks of CVD mortality 
(RR: 0.93; 95% CI: 0.88, 0.99 and RR: 0.61; 95% CI: 
0.42, 0.91, respectively; Figure 3) with evidence of 
heterogeneity (I2 = 74% and I2 = 75%, respectively) and 
publication bias on the funnel plot (see Supplemental 
Figure 4B and Supplemental Figure 4C under 
“Supplemental data” online). Evidence of publication 
bias may be attributed to studies exploring the association 
between nut consumption and death by stroke (23, 24). 
When excluded, the analysis resulted in decreased 
heterogeneity (I2 = 48%) and stabled pooled risk. The 
subgroup analysis of studies evaluating mortality by 
specific CVD outcomes revealed that nut consumption 
was associated with significantly decreased risk of CHD 
death (RR: 0.70, 95% CI: 0.62, 0.79; I2 = 13%) and non-
significant decrease in stroke mortality (RR: 0.84, 95% 
CI: 0.64, 1.09; I2 = 0%). The additional dose-response 
analysis, which included all studies, again strengthened 
the effect size for both weekly (RR: 0.90, 95% CI: 0.87, 
0.92) and daily (RR: 0.48, 95% CI: 0.37, 0.63) 
consumption of nuts on CVD mortality risk (see 
Supplemental Figure 6 under “Supplemental data” 
online).  
Nut consumption and cancer mortality 
Three studies (22-24) accounting for 10,423 deaths from 
cancer were included. There was a significant reduction 
of cancer mortality risk by nut consumption (highest vs. 
lowest category of exposure: RR: 0.86; 95% CI: 0.75, 
0.98; Figure 4), with neither evidence of heterogeneity 
(I2 = 16%) nor publication bias (see Supplemental Table 
2, Supplemental Figure 7 and Supplemental Figure 8 
under “Supplemental data” online). Dose-response 
analysis was estimated pooling HRs of 2 studies (22-24) 
without significant results for both 1-serving of nuts per 
week and per day (Figure 4 and Supplemental Figure 9 
under “Supplemental data” online).  
Background characteristics associated with nut 
consumption 
Detailed information on subjects’ background 
characteristics by nut consumption was reported in 5 
studies (19, 20, 22, 23, 25). Pooled results of slope 
coefficient for meta-analysis of linear association 
between nut consumption and background characteristics 
revealed that each additional serving per week  of nuts 
was associated with increased alcohol intake of about 1 
gram per day (slope coefficient = 0.99, SE 0.79, 1.20), 
increased fruit intake of about 10 gram per day (slope 
coefficient = 9.82, SE 4.5, 15.14), increased vegetable 
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intake of about 13 gram per day (slope coefficient = 
13.28, SE 6.09, 20.46), while BMI and smoking 
prevalence decreased by 0.15 kg/m2 (slope coefficient = - 
0.15, SE -0.24, -0.06) and 0.59% (slope coefficient = - 
0.59, SE -0.99, -0.20), respectively (Figure 5). No 
association of nut consumption with red meat was found. 
Discussion 
This meta-analysis demonstrates consistent results among 
prospective cohort studies supporting decreased risks of 
mortality among individuals with higher nut intake. To 
the best of our knowledge, this is the first meta-analysis 
evaluating the effect of nut consumption on all-cause, 
CVD and cancer mortality.  
While nut consumption and CVD morbidity outcomes 
have been thoroughly researched in the past, mortality 
risk is a relatively recent discussion among researchers. 
Indeed, the first publications demonstrating potential 
benefits of nut consumption on CVD mortality were 
conducted in the early ‘90s, such as the Adventist Health 
Study (17), the Iowa Women Health Study (19) and the 
Physicians Health Study (20). It was only during last few 
years that results from larger cohorts with more detailed 
information were published. The association was 
consistent for all-cause and CVD mortality, whereas the 
result was marginal for cancer mortality as only 3 studies 
examined this outcome (22-24). Although our results did 
not show a significant dose-response effect of nut 
consumption on cancer mortality, there were very limited 
studies available (two) to analyze limiting any 
conclusion.  
Overall, the results from this analysis are convincing 
since a general agreement across studies included was 
observed in the pooled analysis. Recently published 
pooled analyses of prospective studies on nut 
consumption mostly focused on CVD-related morbidities, 
reporting a decreased risk of overall CVD, coronary heart 
disease (CHD), and hypertension (10-13). On the 
contrary, nut consumption was not observed to 
significantly decrease stroke incidence (10), which is in 
line with our results on association of stroke mortality.  
Nuts are considered one of the most nutritional foods as 
they contain high amounts of vegetable protein and 
unsaturated fatty acids. Nuts have a wide variety of 
nutrients including dietary fiber, vitamins (folic acid, 
niacin, tocopherols, and vitamin B6), minerals (calcium, 
magnesium, potassium) and many other bioactive 
constituents such as phytosterols and phenolic 
compounds (26). The unique fat composition of nuts is 
characterized by low saturated fatty acid (SFA) content 
(4–16%) and high monounsaturated fatty acids (MUFA) 
content, such as oleic acid, as well as a variable amount 
of polyunsaturated fatty acids (PUFA), such as α-
linolenic acid (ALA, the plant omega-3 fatty acid), which 
is especially abundant in walnuts (27). Among the other 
compounds that may exert a certain protection against 
CVD, nuts have high content of L-arginine, precursor of 
the endogenous vasodilator nitric oxide, which may 
contribute to vascular reactivity (28). Phytosterols may 
exert a cholesterol-lowering effect by reducing its 
absorption (29). Despite their high content of energy, 
both epidemiological and experimental studies have 
reported that regular nut consumption does not contribute 
to obesity (30), nor does it increase the risk of developing 
metabolic syndrome (31). Their unique fatty acid 
composition is considered one of the key features 
responsible for nuts’ health benefits of nuts, for instance 
in relation to their lipid-lowering and glucose metabolism 
ameliorating effects (4, 32). Among metabolic syndrome 
criteria, a meta-analysis of randomized controlled trials 
with dietary intervention based on nuts administration 
showed lowering in triglycerides and fasting plasma 
glucose compared with control diet interventions (33). 
There was no effect on waist circumference, high-density 
lipoprotein cholesterol or blood pressure, but the 
direction of effect favoring tree nuts for waist 
circumference was established (33). Additionally, another 
meta-analysis demonstrated that nuts improve glycemic 
control in individuals with type 2 diabetes, further 
supporting the inclusion of nuts in a healthy diet (34). 
A number of studies have reported that nut consumption 
was associated with a decreased incidence of pancreatic 
(35) and colorectal cancer (36, 37), whereas some case-
control studies reported a decreased association with 
endometrial (38) and prostate cancer (39), suggesting a 
logical substrate for the marginally significant decreased 
risk of cancer mortality observed in this study. It is 
hypothesized that nuts provide beneficial protection 
against cancer through their anti-oxidant and anti-
inflammatory properties, for instance, by reducing lipid 
peroxidation or oxidative DNA damage (40). Fiber and 
folate in nuts may also play a role in cancer mortality 
prevention. Fiber decreases intestinal mucosa’s exposure 
to carcinogens by increasing anaerobic fermentation and 
reducing intestinal transit duration (31). Folate, a B-
vitamin necessary for normal cellular function, DNA 
synthesis and metabolism, may reduce DNA damage or 
induce repair, and it is thought to play an important role 
in detoxifying homocysteine (41). Although experimental 
studies suggest that nuts may have chemopreventive 
action, especially on colorectal and prostate cancer (40), 
no sufficient evidence confirming their anticancer 
properties is currently available. Further research is 
needed to better understand the potential mechanisms 
through which nuts may decrease cancer risks. 
Potential limitations of the studies included in this meta-
analysis include possible residual confounding effect by 
variables not equally distributed among categories of 
exposure. To further evaluate findings, it is important to 
consider adjustments for potential confounders. Five 
studies (19, 20, 22, 23, 25) included in this meta-analysis 
reported distribution of baseline characteristics of 
participants studied. After pooling together data for 
characteristics that potentially play a role in mortality, we 
reported that nut consumption was associated with lower 
BMI and decreased smoking status. In Bao et al. (23), a 
specific analysis for each potential confounding factor 
was performed to demonstrate that inverse association 
between nut consumption and mortality persisted across 
subgroups, but no further analyses could be retrieved 
from other studies. Similarly, all investigations agreed 
that nut consumption was correlated with fruit, vegetable, 
and alcohol intakes. Although we have limited 
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information on participants’ background characteristics 
from other cohorts, our analyses on studies with 
sufficient data indicate that higher nut consumption was 
positively correlated with healthier background 
characteristics. It is unclear if the protective effects we 
observed are mediated by nut consumption or through the 
clustering healthy food preferences. Nonetheless, nut 
consumption may reflect overall healthier lifestyle 
choices that eventually lead to decreased mortality risk. 
Our study also has some specific limitations. First, cancer 
mortality was assessed only in 3 out of the 9 cohorts 
investigated. Besides the lower statistical power 
compared with other analyses, it is also possible that 
results from other cohorts on nut consumption and cancer 
mortality were not significant and unpublished. Second, 
our analysis indicated an association between nut 
consumption and mortality, but whether or not the 
relationship is independent of other dietary and/or 
lifestyle factors remains unknown. Thus, as suggested 
above, higher nut consumption may be part of better 
nutrition and lifestyle habits that all contributed to 
decreased mortality. Third, questions about specific 
consumption over time, duration, and type of nuts in 
relation with mortality remain to be elucidated. Forth, 
most of the studies included were conducted on specific 
group of individuals with social (i.e., healthcare workers 
(20, 23), post-graduate students (25)) or health-related 
(i.e., individuals at high CVD risk (22)) characteristics 
that differ them from general population. Thus, findings 
from such cohorts may not be universally generalizable.  
In conclusion, nut consumption was inversely associated 
with all-cause, CVD and,  cancer mortality. Future 
research should emphasize exploring more detailed 
background characteristics of the study population in 
order to better isolate the independent effects of nut 
consumption from overall dietary patterns, lifestyle habits 
and mortality. Moreover, more information on the 
specific type of nuts consumed would be of interest in 
order to better identify specific constituents responsible 
for their health benefits. 
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Table 1. Identified prospective cohort studies evaluating nut consumption and all-cause, stroke and cardiovascular (including ischemic coronary 
disease [ICD], coronary heart disease [CHD] and cardiovascular disease [CVD]) mortality. 
Author, year Cohort (country) Gender Age  No. of  Outcome Follow-up No. of  Person- Adjustments Study  
   range subjects   cases years  quality 
Frasier, 1992 (17) Adventists Health  Men and  25+ 26,473 ICD mortality 6 y 463 158,838 Age, gender, smoking status, physical activity,  11 
 Study, non- Women       relative weight, and high blood pressure.  
 hyspanic white           
 (US)          
Frasier, 1997 (18) Adventists Health  Men and  25+ 1668 All-cause  10 y 153 15,893 Age, smoking status, physical activity. 10 
 Study, black (US) Women   mortality      
Ellsworth, 2001  Iowa Women's  Women 55-69 41,836 All-cause  10 y 3726 387,991 Age, energy intake, BMI, waist-to-hip ratio, alcohol  14 
(19) Health Study (US)    mortality, CHD    consumption, smoking status, smoking status,   
      mortality    history of diabetes, history of hypertension, history   
         of estrogen use, physical activity, education,   
         consumption of cereal fibre, eggs, green leafy   
         vegetables, red meat, whole grain foods, and Keys   
         dietary lipid score.  
Albert, 2002 (20) Physicians' Health  Men 40-84 22,071 CHD mortality 17 y 566 366,751 Age, aspirin and beta carotene treatment assignment,  13 
 Study (US)        evidence of CVD before 12-month questionnaire,   
         BMI, smoking status, history of diabetes, history of   
         hypertension, history of hypercholesterolemia,   
         alcohol consumption, vigorous exercise, vitamin E,   
         vitamin C, multivitamin use at baseline, fish   
         consumption, and red meat, fruit, vegetable, and   
         dairy intake at 12 months of follow-up.  
Van den Brandt,  Netherlands  Men and  55-69 120,852 All-cause  10 y 9691 33,872 Age, cigarette smoking status, number of cigarettes  12 
2011 (21) Cohort Study  Women   mortality    smoked per day, years of smoking, BMI,   
 (Netherlands)        hypertension, highest level of education, and energy   
         intake.  
Guasch-Ferré,  PREDIMED  Men and  55-80 7216 All-cause  4.8 y 323 31,077 Age, gender, intervention group, BMI, smoking  13 
2013 (22) Study (Spain) Women   mortality, CVD    status, educational level, leisure time physical   
      mortality,     activity, history of diabetes, history of   
     cancer     hypercholesterolemia, use of oral antidiabetic   
     mortality    medication, use of antihypertensive medication, use   
         of statins, total energy intake, consumption of   
         vegetables, fruits, red meat, eggs, and fish, alcohol   
         intake, and Mediterranean diet adherence.  
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Bao, 2013 (23) Nurses' Health  Women 30-55 76,464 All-cause  30 y 16,200 3,038,853 Age, race, BMI, level of physical activity, status  13 
 Study (US)    mortality, CVD    with regard to smoking, whether a physical   
      mortality,     examination was performed for screening purposes,   
     cancer     current multivitamin use, and current aspirin use,   
     mortality    
status with regard to a family history of diabetes 
mellitus, myocardial infarction, or cancer, status with  
          regard to a history of diabetes mellitus,   
         hypertension, or hypercholesterolemia, intake of   
         total energy, alcohol, red or processed meat, fruits,   
         and vegetables, menopausal status and hormone use.  
Bao, 2013 (23) Health  Men 40-75 42498 All-cause  24 y 11,229 
 
Age, race, body-mass index, level of physical  13 
 Professional     mortality, CVD    activity, status with regard to smoking, whether a   
 Follow-up Study      mortality,     physical examination was performed for screening   
     cancer     purposes, current multivitamin use, and current   
 (US)    mortality    aspirin use, status with regard to a family history of   
         diabetes mellitus, myocardial infarction, or cancer,   
         status with regard to a history of diabetes mellitus,   
         hypertension, or hypercholesterolemia, intake of   
         total energy, alcohol, red or processed meat, fruits,   
         and vegetables.  
Djousse, 2014  Physicians' Health  Men 40-84 20,742 All-cause  9.5 y 2732 
 
Age, BMI, alcohol use, smoking, exercise, energy  12 
(24) Study (US)    mortality, CVD   intake, saturated fat, fruit and vegetables, red meat   
      mortality,     intake, and prevalent diabetes and hypertension.  
     cancer       
     mortality      
Fernandez- SUN Cohort  Men and  18+ 17,184 All-cause  5 y 119 80,010 Age, gender, BMI, smoking, alcohol intake,  13 
Montero, 2014  Study Women   mortality    adherence to the Mediterranean diet, use of special   
(25)         diets, marital status, baseline hypercholesterolemia,   
         hypertension, physical activity, length of television   
         watching, baseline presence of cancer,   
         cardiovascular disease, or diabetes.  
CHD, coronary heart disease; CVD, cardiovascular disease; ICD, ischemic coronary disease; PREDIMED, PREvencion con DIeta MEDiterranea; SUN, Seguimento University of Navarra. 
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Figure 1. Screening and selection process utilized in this systemic review to include studies that 
evaluated nut consumption and mortality risk. 
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Figure 2. Forest plot evaluating pooled risk ratios (RRs) of all-cause mortality by nut consumption. 
Size of the squares is proportional to the percentage weight of each study; horizontal line represents 
95% confidence intervals (CI); diamonds represent pooled estimates and 95% CIs of risk assessed 
by considering nut consumption as category of exposure (highest vs. lowest category of 
consumption) or by dose-response analysis (daily and weekly intake of 1 serving, equivalent to 28 
grams)	through “corrected” linear trends. 
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Figure 3. Forest plot evaluating pooled risk ratios (RRs) of cardiovascular mortality (including 
coronary heart disease and stroke mortality) by nut consumption. Size of the squares is proportional 
to the percentage weight of each study; horizontal line represents 95% confidence intervals (CI); 
diamonds represent pooled estimates and 95% CIs of risk assessed by considering nut consumption 
as category of exposure (highest vs. lowest category of consumption) or by dose-response analysis 
(daily and weekly intake of 1 serving, equivalent to 28 grams) through “corrected” linear trends. 
CHD, coronary heart disease; n.s., not specified. 
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Figure 4. Forest plot evaluating pooled risk ratios (RRs) of cancer mortality by nut consumption. 
Size of the squares is proportional to the percentage weight of each study; horizontal line represents 
95% confidence intervals (CI); diamonds represent pooled estimates and 95% CIs of risk assessed 
by considering nut consumption as category of exposure (highest vs. lowest category of 
consumption) or by dose-response analysis (daily and weekly intake of 1 serving, equivalent to 28 
grams) through “corrected” linear trends. 
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Figure 5. Scatter plot for associations between nut consumption and background characteristics 
including: A) alcohol intake, B) fruit intake, C) vegetable intake, D) red meat intake, E) BMI, and 
F) percentage of smokers. Light lines represent linear regression coefficients of individual studies; 
bold lines represent pooled estimates average increase of each variable per increase of nut intake. 
	
